Skip to main content
Disciplines
Automotive Business IT + Informatics Construction + Real Estate Electrical Engineering + Electronics Energy + Sustainability Insurance + Risk Finance + Banking Management + Leadership Marketing + Sales Mechanical Engineering + Materials
Events
DE
EN
Books
Journals
Topic Page
Marketing
Start single access now
Access for companies
EXTENDED SEARCH
Log in
Top
Published in:
Introduction Read chapter Read first chapter

2014 | OriginalPaper | Chapter

2. Blood Glucose Monitoring Systems

Authors : Francesco Valgimigli, Fabrizio Mastrantonio, Fausto Lucarelli

Published in: Security and Privacy for Implantable Medical Devices

Publisher: Springer New York

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Glucose control is the cornerstone of diabetes mellitus (DM) treatment. Although self-monitoring of blood glucose (SMBG) still remains the best procedure in clinical practise, continuous glucose monitoring systems (CGMSs) provide a dynamic assessment of shifting blood glucose concentrations and facilitate the making of optimal treatment decisions for the diabetic patient. As such, CGM systems could contribute to a paradigm shift in the management of glycaemic control, making insulin administration more personalised. Such an approach makes it possible to narrow the daily glucose fluctuations in blood whilst decreasing the incidence of hypoglycaemic phenomena. This aspect is of paramount importance because improved glycaemic control has been shown to be beneficial to patients – and to the healthcare industry– by reducing the frequency and severity of associated complications [55]. Moreover, tight glycaemic control (TGC) in acutely ill hospitalised patients significantly improves both mortality and morbidity but requires frequent (often hourly) and accurate glucose testing [32, 33]. To meet the specific needs of intensive care units ICUs, specifically designed glucose hospital meters are already commercially available whilst a new generation of intravascular CGM systems is presently under development and clinical testing.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

inform now
previous chapter Introduction
next chapter Wireless System with Multianalyte Implantable Biotransducer
Literature
1.
Wang J., 2008. Electrochemical glucose biosensors, Chem. Rev., 108, 814–825.CrossRef
2.
Reach. G.; Wilason G.S., 1992. Anal. Chem. 64, 381A.
3.
P. D’Orazio, R.W. Burnett, N. Fogh-Andersen, E. Jacobs, K. Kuwa, W.R. Kulpmann, L. Larsson, A. Lewenstam, A.H.J. Maas, G. Mager, J.W. Naskalski, A.O. Okorodudu, 2005. Clin. Chem. 51, 1573–1576.CrossRef
4.
Frank M Brunkhorst and Hans G Wahl.Blood glucose measurements in the critically ill more than just a blood draw. Critical Care 2006, 10:178.CrossRef
5.
Kaplan L.A., Pesce A.J., Clinical Chemistry – Theory, analysis and correlation, 3rd Edition, 1996, Mosby-Year Book, Inc.
6.
Price C. Point-of-care testing in diabetes mellitus. Clinic Chem Lab Med 41 1213–1219, 2003.
7.
Tsuge, H., Natsuakai, O., and Ohashi, K. (1975). J. Biochem. 78, 835–843.
8.
J. Raba and H.A. Mottola, 1995. Glucose oxidase as an analytical reagent. Critical Rev. Anal. Chem., 25, 1–42.CrossRef
9.
10.
Tsujimura S., Kojima S., Kano K., Ikeda T., Sato M., Sanada H., Omura H., 2006. Novel FAD-dependent glucose dehydrogenase for a dioxygen-insensitive glucose biosensor. Biosci. Biotechnol. Biochem. 70, 654–659.CrossRef
11.
A. Heller and B. Feldman, 2008. Electrochemical Glucose Sensors and Their Applications in Diabetes Management. Chem. Rev. 108, 2482–2505.CrossRef
12.
Sode, K., Kojima, K., 1997. Improved substrate specificity and dynamic range for glucose measurement of Escherichia coli PQQ glucose dehydrogenase by site directed mutagenesis. Biotechnol. Lett. 19, 1073–1077.CrossRef
13.
J.G. Hauge, 1964. Glucose Dehydrogenase of Bacterium anitratum: an Enzyme with a Novel Prosthetic Group. J. Biol. Chem. 239, 3630–3639.
14.
Karp G., Cell and Molecular Biology, 5th Ed., Wiley, 2008.
15.
Loach P.A., 1976. In Handbook of Biochemistry and Molecular Biology, 3rd ed. (Fasman, G.D., ed.), Physical and Chemical Data, vol. 1, pp. 122–130, CRC Press, Boca Raton, FL.
16.
Duine, J.A., Frank, J., van Zeeland, J.K., 1979. Glucose dehydrogenase from Acinetobacter calcoaceticus: a ‘quinoprotein’. FEBS Lett. 108, 443–446.CrossRef
17.
Ling. Ye, Martin. Haemmerle, Arjen J. J. Olsthoorn, Wolfgang. Schuhmann, Hans Ludwig. Schmidt, Johannis A. Duine, Adam. Heller. High current density “wired” quinoprotein glucose dehydrogenase electrode. Anal. Chem., 1993, 65 (3), pp 238–241.CrossRef
18.
19.
20.
21.
Nicolas Mano and Adam Heller. Detection of Glucose at 2 fM Concentration. Anal. Chem., 2005, 77, 729–732.CrossRef
22.
Tang Z, Du X, Louie RF, Kost GJ : Effects of drugs on glucose measurements with handheld glucose metes and a portable glucose analyser. Am J Clin Pathol 113: 75–86, 2000.CrossRef
23.
NCCLS Guideline EP7-P, Interference Testing in Clinical Chemistry.
24.
Witt et al., 2000. Biochem. J. 347, 553–559.
25.
Tang Z, Du X, Louie RF, Kost GJ : Effects of pH on glucose measurement with handheld glucose meters and portable glucose analyser for point-of-care testing. Arch Pathol Lab Med 124:577–582, 2000.
26.
B. Innocenti, F. Mastrantonio, “POCT and connectivity: towards the laboratory without boundaries”. Hospital Healthcare Europe, 2005/20 06, L15-L17
27.
Maran A., Crepaldi C., Tiengo A., Grassi G., Vitali E., Pagano G., Bistoni S. et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 25: 347, 2002.CrossRef
28.
Wentholt I.M., Volle Bregt M.A., Hart A.A., Hoekstra J.B., DeVries J.H. Comparison of a needle-type and a microdialysis Continuous Glucose Monitoring in Type 1 Diabetic Patients. Diabetes Care 28: 2871, 2005.CrossRef
29.
Kovatchev B., Anderson S., Heinemann L., Clarke W. Comparison of the Numerical and Clinical Accuracy of Four Continuous Glucose Monitors. Diabetes Care 31: 1160, 2008.CrossRef
30.
Mello G., Parretti E., Tondi F., Bruno S., Iannuzzi L., DiCianni G., La polla A., Messeri D., Poscia A., Correlations between post-prandial glucose areas measured by continuous glucose monitoring (GlucoDay®) and fetal body composition in pregnant women with normal glucose tolerance. Am. J. Obstet. Gynecol. 193: S90, 2005.
31.
De Block C., Keenoy B.M., VanGaal L., Rogiers P., Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care 29: 1750, 2006.CrossRef
32.
Van Den Berghe G., Wouters P., Weekers F., Verweast C. Intensive Insulin Therapy in Critically ill Patients. N. Engl. J. Med. 345: 1359, 2001.CrossRef
33.
Van den Berghe G., Wilmer A., Hermans G., Meersseman W., Wouters P.J., Milants I., Van Wijngaerden E., Bobbaers H., Bouillon R. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 354: 449, 2006.CrossRef
34.
Pfeiffer E.F., Thum C., Clemens A. The artificial beta cell. A continuous control of blood sugar by external regulation of insulin infusion. Horm. Metabol. Res. 6: 339, 1974.CrossRef
35.
Fogt E.J., Dodd L.M., Jenning E.M., Clemens A.H. Development and evaluation of a glucose analyzer for a glucose-controlled insulin infusion system (Biostator®). Clin. Chem. 24(8): 1366, 1978.
36.
Keenan D.B., Cartaya R., Mastrototaro J.J. Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm. J. Diabetes Sci. Technol. 4(1): 111, 2010.
37.
Bode B., Gross K., Rikalo N., Schwartz S., Wahl T., Page C., Gross T., Mastrototaro J.J. Alarms based on real time sensor glucose values alert patients to hypo and hyper glycemia: the Guardian Continuous Monitoring System. Diabetes Technol. Ther. 6: 105, 2004.CrossRef
38.
Mastrototaro J.J., Shin J., Marcus A., Sulur G. The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes. Diabetes Technol. Ther. 10(5): 385, 2008.CrossRef
39.
Blevins T.C. Professional Continuous Glucose Monitoring in Clinical Practice 2010. J. Diabetes Sci. Technol. 4(2): 440, 2010.
40.
Weinstein R.L., Bugler J.R., Schwartz S.L., Peyser T.A., Brazg R.L., McGarraugh G.V. Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Care 30 (5): 1125, 2007.CrossRef
41.
McGarraugh G., Bergenstal R. Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System. Diabetes Technol. Ther. 11(3): 145, 2009.CrossRef
42.
Garg S., Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 29(12): 2644, 2006.CrossRef
43.
Kamath A., Mahalingham A., Brauker J. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor. Diabetes Technol. Ther. 11(11): 689, 2009.CrossRef
44.
Poscia A., Mascini M., Moscone D., Luzzana M., Caramenti G., Cremonesi P., Valgimigli F., Bongiovanni C., Varalli M. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1). Biosens. Bioelectron. 18: 891, 2003.CrossRef
45.
Varalli M., Marelli G., Maran A., Bistoni S., Luzzana M., Cremonesi P., Caramenti G., Valgimigli F., Poscia A. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 2). Biosens. Bioelectron 18: 899, 2003.CrossRef
46.
De Block C., Vertommen J., Manuel-y-Keenoy B., Van Gaal L. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects. Curr. Diabetes Rev. 4(3): 159, 2008.CrossRef
47.
Hermanns N., Kulzer B., Gulde C., Eberle H., Pradler E., Patzelt-Bath A., Haak T. Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study. Diabetes Technol. Ther. 11(5): 275, 2009.CrossRef
48.
Anke Sieg, Richard H. Guy, M. Begoña Delgado-Charro: Non-invasive Glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin. Chem. 50(8): 1383, 2004.CrossRef
49.
Wentholt I.M.E., Hoekstra J.B.L., Zwart A., DeVries J.H. Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia 48: 1055, 2005.CrossRef
50.
Valgimigli F., Lucarelli F., Scuffi C., Morandi S., Sposato I. Evaluating the clinical accuracy of GlucoMen®Day: a novel microdialysis-based continuous glucose monitor. J. Diabetes Sci. Technol. 4 (5): 1182, 2010.
51.
Peyser T., Zisser H., Khan U., Jovanovic L., Bevier W., Romey M., Suri J., Strasma P., Tiaden S. Gamsey S., Use of a novel fluorenscent glucose sensor in volunteer subjects with Type 1 Diabetes Mellitus J. Diabetes Sci. Technol. 5(3): 687, 2011.
52.
Jax T., Heise T., Nosek L., Gable J., Lim G., Calentine C. Automated Near-Continuous Glucose Monitoring Measured in Plasma Using Mid-Infrared Spectroscopy J. Diabetes Sci. Technol. 5(2): 345, 2011.
53.
Möller F., Liska J., Eidhagen F., Franco-Cereceda A. Intravascular Microdialysis as a Method for Measuring Glucose and Lactate during and after Cardiac Surgery J. Diabetes Sci. Technol. 5(5): 1099, 2011.
54.
Lucarelli F., Ricci F., Caprio F., Valgimigli F., Scuffi C., Moscone D., Palleschi G. GlucoMen Day continuous glucose monitoring system: a screening for enzymatic and electrochemical interferents J. Diabetes Sci. Technol. 6(5): 1172, 2012.
55.
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus, The Diabetes Control and Complications Trial (DCCT) Research Group, N Engl J Med 1993; 329
56.
Sparacino G., Zanon M., Facchinetti A., Zecchin C., Maran A. Cobelli C. Italian Contributions to the Development of Continuous Glucose Monitoring Sensors for Diabetes Management Sensors 2012, 12, 13753–13780CrossRef
57.
M.J. Rice, D.B. Coursin Continuous Measurement of Glucose - Facts and Challenges., Anesthesiology 116 (1), 199, 2012CrossRef
58.
J.-C. Preiser, The Future of Glucose Control in the ICU. ICU Management, 13 (1), 24. 2013
59.
J.S. Krinsley et al., Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit. Care 17, R37, 2013.CrossRef
60.
Jeffrey I Joseph, D.O. Analysis: New Point-of-Care Blood Glucose Monitoring System for the Hospital Demonstrates Satisfactory Analytical Accuracy Using Blood from Critically Ill Patients—An Important Step toward Improved Blood Glucose Control in the Hospital Journal of Diabetes Science and Technology Volume 7, Issue 5, September 2013
61.
J. Newman A, Turner Home blood glucose biosensors: a commercial perspective Biosensors & Bioelectronics (20) 2005 2435–2453
62.
N.S. Oliver et al. Glucose sensors: a review of current and emerging technology Diabetic Medicine 2009 26, 197–210
63.
D. Zahn et al. Novel device for quick measurement of glucose in POCT areas without pre-analytical steps based on multi-way glucose biosensor, Eng. Life Sci. 2009, 9 n. 5, 398–403CrossRef
64.
Simon Finfer, Jan Wernerman, Jean-Charles Preiser, Tony Cass, Thomas Desaive, Roman Hovorka, Jeffrey I Joseph, Mikhail Kosiborod, James Krinsley MD, Iain Mackenzie, Dieter Mesotten, Marcus Schulz, Mitchell G. Scott, Robert Slingerland, Greet Van den Berghe, Tom Van Herpe, Consensus Recommendations on “Measurement of Blood Glucose and Reporting Glycemic Control in Critically Ill Adults” Critical Care 2013, 17: 229CrossRef
65.
Kaczmarek E, Guerra E, Mosca A, Mastrantonio F, Lucarelli F, Valgimigli F, Ceriotti F, “Comparative assessment of the performances of the StatStrip point-of-care testing device for the measurements of ketone bodies.”, Biochimica Clinica, 2013, vol. 37, SS S683.
66.
Rooyackers O., Blixt P, Wernerman J, “Continuos glucose monitoring by intravenous microdyalysis: influence of membrane length and dialysis flow-rate”, Acta Anesthesiol.Scand., 2012
67.
Tang Z, Louie R, Payes M, Chang K, Kost G: Oxygen effects on glucose measurements with a reference analyzer and three handheld meters. Diabetes Technol Ther 2000, 2:349–362CrossRef
68.
Tang Z, Du X, Louie R, Kost G: Effects of pH on glucose measurements with handheld glucose meters and a portable glucose analyzer for point-of-care testing. Arch Pathol Lab Med 2000, 124:577–582
69.
Chance J, Li D, Jones K, Dyer K, Nichols J: Technical evaluation of five glucose meters with data management capabilities. Am J Clin Path 1999, 111:547–556
70.
Louie R, Tang Z, Sutton D, Lee J, Kost G: Point-of-care glucose testing. Arch Pathol Lab Med 2000, 124:257–266
71.
Tang Z, Lee J, Louie R, Kost G: Effects of different haematocrit levels on glucose measurements with handheld meters for point-of-care testing. Arch Pathol Lab Med 2000, 124:1135–1140
72.
Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 47: 209–14 (2001)
73.
Mann E, Salinas J, Pidcoke H et al Error rates resulting from Anemia can be corrected in multiple commonly used point of care glucometers J Trauma 2008 64:15 – 21.CrossRef
74.
Krinsley J, Grover A. Severe hypoglycaemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35: 2262–2267CrossRef
75.
C.L.S.I., Point of care blood glucose testing in acute and chronic care facilities; approved guideline - Third edition. POCT12-A3. 2013. 33(2)
76.
Karon B Griemann L Scott R et al Evaluation of the Impact of Haematocrit and Other Interference on the Accuracy of Hospital-Based Glucose Meters. Diabetes Technology & Therapeutics 2008 10, Number 2, 111–120CrossRef
77.
Holtzinger C Szelag, E. DuBois, et al. Evaluation of a New POCT Bedside Glucose Meter and Strip With Haematocrit and Interference Corrections Point of Care 2008 7, Number 1 1–6.
78.
Hopf S, Graf, B., and Gruber, M Comparison of Point-of-Care Testing Glucose Results from Intensive Care Patients Measured with Network-Ready Devices, Diabetes Technology & TherapeuticsVolume 13, Number 10, 2011
79.
International Organization for Standardization (ISO). In vitro diagnostic test systems. Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. International Standard ISO 15197:2013
80.
Kovatchev et al. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose–error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004;27:1922–1928
81.
Ellmerer et al. Clinical evaluation of alternative-site glucose measurements in patients after major cardiac surgery. Diabetes Care. 2006;29(6):1275–1281.
82.
The NICE-SUGAR Study Investigators. Intensive versus Conventional Glucose Control in Critically Ill Patients. N Engl J Med 2009; 360:1283–1297CrossRef
83.
L. Heinemann et al. Reimbursement for Continuous Glucose Monitoring: A European View Journal of Diabetes Science and Technology Volume 6, Issue 6, November 2012
84.
Mastrantonio F., Valgimigli F., Grassi L., Cappa P., De Micheli G., Carrara S., “Comparative Performance of Different Nanostructured Electrochemical Sensors on Insulin Detection” BioNanoSci., 2013 3:285–288
85.
Brunner R, Kitzberger R, Miehsler W, Herkner H, Madl C, Holzinger U., Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. Crit Care Med. 2011; 16:659–664
Metadata
Title
Blood Glucose Monitoring Systems
Authors
Francesco Valgimigli
Fabrizio Mastrantonio
Fausto Lucarelli
Copyright Year
2014
Publisher
Springer New York
Book
Security and Privacy for Implantable Medical Devices

Print ISBN: 978-1-4614-1673-9

Electronic ISBN: 978-1-4614-1674-6

Copyright Year: 2014

DOI
https://doi.org/10.1007/978-1-4614-1674-6_2